Digirad said it continues to achieve positive cash flow and improved gross margins in its imaging solutions unit for the third quarter ended Sept. 30. The company said it is on its way to gain positive net earnings for 2009 despite lower sales in nuclear gamma cameras. "We believe our new proprietary Cardius X-ACT imaging system, introduced earlier this year, is ideally suited for large volume nuclear medicine departments and practices. We believe that we are well positioned to grow our revenues and market share when the economic recovery begins," CEO Todd Clyde said.
Published in Brief: